Nagendran Sukumar
SEC insider (Form 3/4/5 filer). CIK 0001665124. President and Head of R&D at Taysha Gene Therapies, Inc. (TSHA) and 1 other issuer. 20 reported Form 4/5 transactions since Sep 2024; latest on Jul 10, 2026. Located in DALLAS, TX.
Companies Nagendran Sukumar has filed insider reports for
- Taysha Gene Therapies, Inc. (TSHA): Director, Officer, President and Head of R&D
- Solid Biosciences Inc. (SLDB): Director
Nagendran Sukumar
CIK: 0001665124
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Jul 10, 2026TSHA
Taysha Gene Therapies, Inc.
SaleDirect200K shares at avg. $6.24$1.2M - Jun 10, 2026SLDB
Solid Biosciences Inc.
AwardDirectDirector Stock Option (Right to Buy)
77.5K shares- - Apr 10, 2026TSHA
Taysha Gene Therapies, Inc.
ExerciseDirect19K shares at avg. $1.71$33K - Apr 10, 2026TSHA
Taysha Gene Therapies, Inc.
SaleDirect200K shares at avg. $4.46$892K - Jan 26, 2026TSHA
Taysha Gene Therapies, Inc.
SaleDirect26.9K shares at avg. $4.61$124K - Jan 23, 2026TSHA
Taysha Gene Therapies, Inc.
SaleDirect89.1K shares at avg. $4.75$423K - Jan 12, 2026TSHA
Taysha Gene Therapies, Inc.
ExerciseDirect111.3K shares at avg. $0.70$78K - Jan 12, 2026TSHA
Taysha Gene Therapies, Inc.
AwardDirect427K shares- - Jan 12, 2026TSHA
Taysha Gene Therapies, Inc.
SaleDirect200K shares at avg. $4.71$942K - Jan 12, 2026TSHA
Taysha Gene Therapies, Inc.
ExerciseDirect88.7K shares at avg. $1.71$152K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 10, 2026 |  TSHA Taysha Gene Therapies, Inc. | Sale | 200,000 | $6.24 | $1,248,000 | Direct |
| Jun 10, 2026 |  SLDB Solid Biosciences Inc. | Award Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Apr 10, 2026 | TSHA Taysha Gene Therapies, Inc. | Exercise | 19,021 | $1.71 | $32,526 | Direct |
| Apr 10, 2026 | TSHA Taysha Gene Therapies, Inc. | Sale | 200,000 | $4.46 | $892,000 | Direct |
| Jan 26, 2026 | TSHA Taysha Gene Therapies, Inc. | Sale | 26,918 | $4.61 | $124,092 | Direct |
| Jan 23, 2026 | TSHA Taysha Gene Therapies, Inc. | Sale | 89,132 | $4.75 | $423,377 | Direct |
| Jan 12, 2026 | TSHA Taysha Gene Therapies, Inc. | Exercise | 111,324 | $0.70 | $77,804 | Direct |
| Jan 12, 2026 | TSHA Taysha Gene Therapies, Inc. | Award | 427,000 | - | $0 | Direct |
| Jan 12, 2026 | TSHA Taysha Gene Therapies, Inc. | Sale | 200,000 | $4.71 | $942,000 | Direct |
| Jan 12, 2026 | TSHA Taysha Gene Therapies, Inc. | Exercise | 88,676 | $1.71 | $151,636 | Direct |
1-10 of 20 transactions